This cross-sectional and exploratory study was performed with the participation of 152 GPs working at primary health centers and hospitals in order to find the effect of pharmaceutical promotion ...
The target LDL-C level is progressively lower as the risk for CHD increases. The measured LDL-C level at which drug therapy should be initiated also is lower asthe risk for CHD increases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback